Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic hepatitis B vaccine plus adefovir dipivoxil in HBeAg-positive chronic hepatitis B
ChiCTR-TRC-11003189Phase 2Completed
- Sponsor
- Beijing Ditan Hospital
- Start
- Dec 2011
- Modality
- Small Molecules, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Hepatitis B vaccine and adefovir dipivoxil in Chronic Hepatitis B (CHB) (3 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: HBeAg seroconversion. Started Dec 2011; status: completed.
02
Drugs
Hepatitis B vaccineadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-11003189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11003189.